etoposide has been researched along with HIV Coinfection in 64 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (10.94) | 18.2507 |
| 2000's | 17 (26.56) | 29.6817 |
| 2010's | 26 (40.63) | 24.3611 |
| 2020's | 14 (21.88) | 2.80 |
| Authors | Studies |
|---|---|
| Arun, VA; Bal, A; Jain, A; Malhotra, P | 1 |
| Allione, B; Angelillo, P; Cattaneo, C; Erbella, F; Facchetti, F; Ferreri, AJM; Flospergher, E; Foppoli, M; Lleshi, A; Pagani, C; Pecciarini, L; Ponzoni, M; Re, A; Rossi, G; Sassone, M; Spina, M; Steffanoni, S; Verga, L | 1 |
| Bassett, IV; Busakhala, N; Byakwaga, H; Freedberg, KA; Freeman, EE; Hajny Fernandez, ME; Hyle, EP; Kiprono, S; Laker-Oketta, M; Martin, JN; Maurer, T; McCann, NC; Pei, PP; Reddy, KP; Semeere, A | 1 |
| Argy, N; Debus, J; Guiraud, V; Herbel, S; Ricard, JD; Roux, D; Tetelboum, N; Thy, M; Verney, C; Zucman, N | 1 |
| Cheshenko, N; Herold, BC; Herold, KC; Kravets, L; Krishnaswamy, S; Loh, LN; Nassar, M; Philbrick, W; Pierce, CA; Preston-Hurlburt, P; Sidoli, S; Steach, HR; Stransky, S; Zhang, F | 1 |
| Borok, M; Bukuru, A; Busakhala, N; Campbell, TB; Chang, D; Epeldegui, M; Godfrey, C; Hoagland, B; Hosseinipour, MC; Kang, M; Kanyama, C; Krown, SE; Langat, D; Lee, J; Magpantay, LI; Martínez-Maza, O; Mngqibisa, R; Mwelase, N; Nyirenda, M; Samaneka, W | 1 |
| Chikasema, M; Chimzimu, F; Chiyoyola, S; Ellis, GK; Fedoriw, G; Gopal, S; Kaimila, B; Kampani, C; Kasonkanji, E; Mhango, W; Montgomery, ND; Mtangwanika, A; Mulenga, M; Nicholas, S; Nyasosela, R; Nyirenda, R; Painschab, MS; Randall, C; Tewete, B; Tomoka, T; Westmoreland, KD; Zuze, T | 1 |
| Aboulafia, D; Ambinder, RF; Cesarman, E; Chadburn, A; Henry, DH; Kaplan, LD; Lee, JY; Mitsuyasu, R; Noy, A; Ramos, JC; Ratner, L; Sparano, JA; Wachsman, W | 1 |
| Borok, M; Campbell, TB; Caruso, S; Dittmer, DP; Godfrey, C; Hoagland, B; Hosseinipour, MC; Kang, M; Krown, SE; Martinez-Maza, O; Mngqibisa, R; Mwelase, N; Ngongondo, M; Nyirenda, M; Samaneka, W; Umbleja, T | 1 |
| Aboulafia, D; Ambinder, RF; Baiocchi, R; Capoferri, AA; Cesarman, E; Chadburn, A; Durand, CM; Kaplan, L; Lee, JY; Mitsuyasu, R; Moore, PC; Noy, A; Ramos, JC; Ratner, L; Reid, EG; Rubinstein, PG; Siegel, ER; Sparano, JA | 1 |
| Alves, AR; Cipriano, P; Cristina, S; Toscano, M | 1 |
| Ddungu, H; Mulumba, Y; Okello, CD; Omoding, A; Orem, J | 1 |
| Allione, B; Calimeri, T; Cattaneo, C; Donadoni, G; Facchetti, F; Ferrari, D; Ferreri, AJM; Foppoli, M; Fumagalli, L; Lleshi, A; Pecciarini, L; Ponzoni, M; Re, A; Rigacci, L; Rossi, G; Sassone, M; Spina, M; Verga, L | 1 |
| Fazal, F; Gupta, N; Mittal, A; Ray, A | 1 |
| Kobayashi, H; Miyagi, N | 1 |
| Bailey, S; Chagaluka, G; Chakmata, E; Dale, H; Depani, S; Israels, T; Macken, M; Molyneux, EM; Moyo, D; Niyrenda, D | 1 |
| Caswell, SJ; Gupta, RK; Mlcochova, P; Taylor, IA; Towers, GJ | 1 |
| Baars, JW; Brouwer, R; Chamuleau, MED; de Jong, D; de Wreede, LC; Demandt, AMP; Doorduijn, JK; Hardi, L; Kersten, MJ; Kluin, PM; Nijland, M; Oosten, LEM; Siemes, C; Smeekes, OS; Stevens, WBC; Thielen, FW; Uyl-de Groot, CA; van Imhoff, GW; Veelken, H | 1 |
| Ambinder, R; Borok, M; Bukuru, A; Busakhala, N; Campbell, TB; Dittmer, DP; Godfrey, C; Hoagland, B; Hosseinipour, MC; Kang, M; Krown, SE; Langat, D; MacRae, J; Martin, JN; Martínez-Maza, O; Mngqbisa, R; Moses, A; Mwelase, N; Nokta, M; Nyirenda, M; Orem, J; Samaneka, W; Umbleja, T | 1 |
| Jeng, A; Tulloch, LG; Younes, R | 1 |
| Bai, QX; Chen, XQ; Dong, HJ; Feng, J; Gao, GX; Gu, HT; Liang, R; Shu, MM; Xu, L; Yang, L; Zhang, N | 1 |
| Aboulafia, D; Ambinder, RF; Cesarman, E; Henry, D; Lee, J; Looney, D; Maldarelli, F; Mitsuyasu, R; Noy, A; Ramos, JC; Reid, EG; Sparano, J; Wachsman, W; Yahyaei, S | 1 |
| Masamba, L; Mtonga, P; Mwafulirwa, K; Nyirenda, R | 1 |
| Barta, SK; Boue, F; Dunleavy, K; Galicier, L; Garcia, O; Kaplan, LD; Lee, JY; Little, RF; Morgades, M; Mounier, N; Navarro, JT; Noy, A; Oriol, A; Ratner, L; Remick, SC; Ribera, JM; Sparano, JA; Spina, M; Tamari, R; Tirelli, U; Wang, D; Weiss, R; Wilson, WH; Wyen, C; Xue, X | 1 |
| Levine, AM | 2 |
| Bailey, S; Banda, K; Chagaluka, G; Depani, S; Israels, T; Katangwe, T; Molyneux, E; Mukaka, M; Nijram'madzi, J; Stanley, C | 1 |
| Hensel, M; Hentrich, M; Hoffmann, C; Mosthaf, F; Müller, M; Siehl, J; Wyen, C | 1 |
| Battegay, M; Krasniqi, F; Kurz, M; Marzolini, C; Stoeckle, M | 1 |
| Dedicoat, M; Freeman, EE; Gbabe, OF; Okwundu, CI | 1 |
| Johnson, DH; Reske, T; Ruiz, M | 1 |
| Ambinder, R; Baiocchi, R; Cesarman, E; Kaplan, L; Lee, JY; Noy, A; Ratner, L; Reid, E; Wagner-Johnston, N | 1 |
| Bendle, M; Boffito, M; Bower, M; Dalla Pria, A; Ramaswami, R | 1 |
| Hagiwara, S; Kawabata, KC; Miwa, A; Oka, S; Tachikawa, N; Takenouchi, A; Tanimura, A; Tanuma, J | 1 |
| Bower, M; Charles, P; Ibrahim, H; Kelleher, P; Naresh, KN; Nelson, M; Ngan, S; Stebbing, J | 1 |
| Oksenhendler, E | 1 |
| Abdallah, FK; Ayers, LW; Bako, J; Banura, C; Black, J; Fu, P; Johnson, JL; Kakembo, J; Katongole-Mbidde, E; Lederman, MM; Meyerson, HJ; Mwanda, WO; Ness, A; Onyango, CA; Orem, J; Remick, SC; Reynolds, S; Subbiah, V; Wabinga, H; Whalen, CC | 1 |
| Brantly, ML; Campos, MA; Chapman, KR; Kueppers, F; Sandhaus, RA; Stocks, JM; Strange, C; Turino, G; Wang-Smith, L | 1 |
| Abramson, JS; Barnes, JA; Feng, Y; Hochberg, EP; Lacasce, AS; Michaelson, JS; Neuberg, D; Toomey, CE | 1 |
| Bower, M; Gazzard, B; Lee, B; Merchant, S; Naresh, K; Nelson, M; Newsom-Davis, T; Stebbing, J | 1 |
| Achermann, Y; Fehr, J; Lederer, H; Stenner, F; Tinguely, M | 1 |
| Aragon-Ching, JB; El-Ayass, W; Karcher, DS; Yu, EM | 1 |
| Castillo, JJ; Echenique, IA | 1 |
| Degnan, AJ; Levy, LM | 1 |
| Alt, J; Arasteh, K; Berger, M; Engert, A; Fätkenheuer, G; Hentrich, M; Hoffmann, C; Mosthaf, F; Müller, M; Nickelsen, M; Planker, M; Rieke, A; Rockstroh, JK; Schmidmaier, R; Schürmann, D; Seidel, E; Siehl, J; Wolf, T; Wyen, C | 1 |
| Ammassari, A; Antinori, A; di Gennaro, G; Fasan, M; Gabarre, J; Mena, M; Nigra, E; Rossi, G; Schiantarelli, C; Spina, M; Talamini, R; Tirelli, U; Vaccher, E | 1 |
| Diehl, V; Franzen, C; Hartmann, P; Rehwald, U; Salzberger, B; Sieber, M; Wöhrmann, A | 1 |
| Aboulafia, DM; Dezube, BJ; Pantanowitz, L | 1 |
| Bushman, F; Groschel, B | 1 |
| Kaplan, LD | 1 |
| Bradbeer, C; Collins, L; de Ruiter, A; Fowler, A; Kulasegaram, R; Whittaker, S | 1 |
| Abbott, BL; Chen, R; Myint, H | 1 |
| Al-Saleem, T; Jambusaria, A; Perlis, C; Shafer, D; Wu, H | 1 |
| Collazos, J; Gallardo, M; Hernando, G; Rodriguez, J | 1 |
| Bennett, JM; Feldstein, ML; Kahn, JO; Krown, SE; Lin, S; Metroka, CE; Paredes, J; Ratner, L; Tong, WP | 1 |
| Becker, N; Leaf, A; Sparano, JA; Strack, M; Valentine, ES; Wiernik, PH | 1 |
| Errante, D; Gastaldi, R; Magnani, G; Nigra, E; Nosari, AM; Spina, M; Tirelli, U; Vaccher, E | 1 |
| Albrecht, H; Berger, J; Meigel, W; Plettenberg, A; Stellbrink, HJ; Stoehr, A; van Dyk, U | 1 |
| Gougeon, ML; Naora, H | 1 |
| Fasan, M; Gabarre, J; Spina, M; Tirelli, U; Vaccher, E | 1 |
| Gutierrez, M; Horne, M; Jaffe, ES; Little, RF; Pau, A; Wilson, W | 1 |
| Cabral, L; Harrington, WJ; Scott, D | 1 |
| Barber, GN; Boise, LH; Cabral, L; Deyev, VV; Harrington, WJ; Liu, LH; Podack, ER; Scott, D; Toomey, NL; Wood, C | 1 |
| Cohen, P; Dawkins, F; Holmlund, J; Schulof, RS; Shields, PG | 1 |
10 review(s) available for etoposide and HIV Coinfection
| Article | Year |
|---|---|
Haemophagocytic lymphohistiocytosis in human immunodeficiency virus: a systematic review of literature.
Topics: Adult; Anti-Retroviral Agents; Etoposide; Female; HIV; HIV Infections; Humans; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Neoplasms; Opportunistic Infections; Retrospective Studies; Steroids; Topoisomerase II Inhibitors | 2020 |
Reactive hemophagocytic syndrome in the setting of acute human immunodeficiency virus 1 infection: case report and review of the literature.
Topics: Adrenal Cortex Hormones; Adult; Anti-Retroviral Agents; Etoposide; Exanthema; Histiocytosis; HIV Infections; HIV-1; Humans; Injections, Spinal; Lymphohistiocytosis, Hemophagocytic; Male; Methotrexate; Treatment Outcome | 2018 |
Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients.
Topics: Anti-HIV Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; HIV; HIV Infections; Humans; Infusions, Intravenous; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Prednisone; Rituximab; Survival Analysis; Treatment Outcome; Vincristine | 2013 |
Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults.
Topics: Alitretinoin; Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Bleomycin; Doxorubicin; Drug Therapy, Combination; Etoposide; HIV Infections; Humans; Liposomes; Observational Studies as Topic; Randomized Controlled Trials as Topic; Sarcoma, Kaposi; Skin Neoplasms; Tretinoin; Vincristine | 2014 |
Case report and review of immunodeficiency-associated Burkitt lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Doxorubicin; Etoposide; HIV Infections; Humans; Male; Methotrexate; Prednisone; Remission Induction; Rituximab; Vincristine | 2015 |
HIV-associated multicentric Castleman disease.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Asparaginase; Castleman Disease; Clinical Trials as Topic; Cytarabine; Daunorubicin; Etoposide; Ganciclovir; Herpesviridae Infections; Herpesvirus 8, Human; HIV Infections; Humans; Lymph Nodes; Rituximab; Thioguanine; Valganciclovir; Virus Replication | 2009 |
Complete response to EPOCH in a patient with HIV and extracavitary primary effusion lymphoma involving the colon: a case report and review of literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; HIV Infections; Humans; Lymphoma, Primary Effusion; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Treatment Outcome; Vincristine | 2012 |
Rituximab in combination with chemotherapy versus chemotherapy alone in HIV-associated non-Hodgkin lymphoma: a pooled analysis of 15 prospective studies.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; HIV Infections; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Odds Ratio; Prednisone; Prospective Studies; Randomized Controlled Trials as Topic; Rituximab; Treatment Outcome; Vincristine | 2012 |
Challenges in the management of Burkitt's lymphoma.
Topics: Adult; Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bleomycin; Burkitt Lymphoma; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Enzyme Inhibitors; Etoposide; HIV Infections; Humans; Ifosfamide; Leucovorin; Methotrexate; Time Factors; Treatment Outcome; Urate Oxidase; Vincristine | 2002 |
AIDS-related non-Hodgkin lymphoma: still a problem in the era of HAART.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Cyclophosphamide; Doxorubicin; Etoposide; Female; HIV Infections; Humans; Incidence; Lymphoma, AIDS-Related; Male; Middle Aged; Prednisone; Radiography; Registries; United States; Vincristine | 2004 |
15 trial(s) available for etoposide and HIV Coinfection
| Article | Year |
|---|---|
Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV-associated, B-cell non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Cyclophosphamide; Doxorubicin; Etoposide; HIV Infections; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Prednisone; Prospective Studies; Rituximab; Vincristine | 2021 |
Early Progression and Immune Reconstitution Inflammatory Syndrome During Treatment of Mild-To-Moderate Kaposi Sarcoma in Sub-Saharan Africa and South America: Incidence, Long-Term Outcomes, and Effects of Early Chemotherapy.
Topics: Adult; Africa South of the Sahara; Anti-HIV Agents; Antineoplastic Agents, Phytogenic; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Disease Progression; Etoposide; Female; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Male; Sarcoma, Kaposi; South America; Treatment Outcome | 2020 |
Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial).
Topics: Adult; Aged; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; CD4 Lymphocyte Count; Cyclophosphamide; DNA, Viral; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Genes, myc; Herpesviridae Infections; Herpesvirus 4, Human; Herpesvirus 8, Human; Histone Deacetylase Inhibitors; HIV Infections; HIV-1; Humans; Kaplan-Meier Estimate; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Prednisone; Progression-Free Survival; Prospective Studies; Rituximab; Thrombocytopenia; Treatment Outcome; Vincristine; Viral Load; Vorinostat | 2020 |
A dose-dense short-term therapy for human immunodeficiency virus/acquired immunodeficiency syndrome patients with high-risk Burkitt lymphoma or high-grade B-cell lymphoma: safety and efficacy results of the "CARMEN" phase II trial.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Burkitt Lymphoma; Carmustine; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; HIV Infections; Humans; Lymphoma, B-Cell; Male; Melphalan; Middle Aged; Transplantation, Autologous | 2021 |
As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial.
Topics: Administration, Oral; Adult; Africa South of the Sahara; AIDS-Related Opportunistic Infections; Antineoplastic Agents, Phytogenic; Antiretroviral Therapy, Highly Active; Biopsy; Etoposide; Female; Health Resources; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Male; Sarcoma, Kaposi; Skin; South America | 2018 |
Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; APOBEC-3G Deaminase; Bortezomib; Carboplatin; Etoposide; Female; HIV; HIV Infections; Humans; Ifosfamide; Leukocytes, Mononuclear; Lymphoma; Male; Middle Aged; Oncolytic Virotherapy; Recurrence; Rituximab; Viral Load | 2018 |
Kaposi's sarcoma in children: an open randomised trial of vincristine, oral etoposide and a combination of vincristine and bleomycin.
Topics: Administration, Oral; Adolescent; Anti-Retroviral Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Etoposide; Female; HIV Infections; Humans; Male; Quality of Life; Sarcoma, Kaposi; Survival Rate; Treatment Outcome; Vincristine | 2014 |
AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; HIV Infections; HIV-1; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Rituximab; Treatment Outcome; Vincristine; Young Adult | 2015 |
Pharmacokinetic comparability of Prolastin®-C to Prolastin® in alpha₁-antitrypsin deficiency: a randomized study.
Topics: alpha 1-Antitrypsin; alpha 1-Antitrypsin Deficiency; Antineoplastic Combined Chemotherapy Protocols; Double-Blind Method; Etoposide; Female; HIV Infections; Humans; Male; Malnutrition; Mitoxantrone; Prednisone; Protease Inhibitors; Vincristine | 2010 |
Stage-adapted treatment of HIV-associated Hodgkin lymphoma: results of a prospective multicenter study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; HIV Infections; Hodgkin Disease; Humans; Lymphoma, AIDS-Related; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Prospective Studies; Remission Induction; Treatment Outcome; Vinblastine; Vincristine; Young Adult | 2012 |
Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bleomycin; Disease-Free Survival; Doxorubicin; Etoposide; HIV Infections; HIV-1; Hodgkin Disease; Humans; Lymphoma, AIDS-Related; Male; Mechlorethamine; Middle Aged; Prednisone; Prognosis; Prospective Studies; Remission Induction; Survival Analysis; Survival Rate; Vinblastine; Vincristine | 2002 |
BEACOPP therapeutic regimen for patients with Hodgkin's disease and HIV infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD4 Lymphocyte Count; Cyclophosphamide; Doxorubicin; Etoposide; Female; HIV Infections; Hodgkin Disease; Humans; Immunocompromised Host; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; RNA; Treatment Outcome; Vincristine | 2003 |
Weekly oral etoposide in patients with Kaposi's sarcoma associated with human immunodeficiency virus infection: a phase I multicenter trial of the AIDS Clinical Trials Group.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Chromatography, High Pressure Liquid; Drug Administration Schedule; Drug Tolerance; Etoposide; HIV Infections; HIV-1; Humans; Male; Sarcoma, Kaposi | 1995 |
Second-line chemotherapy in human immunodeficiency virus-related non-Hodgkin's lymphoma: evidence of activity of a combination of etoposide, mitoxantrone, and prednimustine in relapsed patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; HIV Infections; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednimustine; Prognosis; Prospective Studies; Recurrence; Survival Rate | 1996 |
Stanford V regimen and concomitant highly active antiretroviral therapy is feasible and active in patients with Hodgkin's disease and HIV infection.
Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Etoposide; Female; HIV; HIV Infections; Hodgkin Disease; Humans; Lymphoma, AIDS-Related; Male; Mechlorethamine; Middle Aged; Prednisone; Vinblastine; Vincristine | 2000 |
39 other study(ies) available for etoposide and HIV Coinfection
| Article | Year |
|---|---|
Primary chest wall Burkitt lymphoma in a case of HIV infection with immune reconstitution.
Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Doxorubicin; Etoposide; HIV Infections; Humans; Immune Reconstitution; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prednisone; Rituximab; Thoracic Wall; Vincristine | 2021 |
Safety and efficacy of a dose-dense short-term therapy in patients with MYC-translocated aggressive lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; COVID-19; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; HIV Infections; Humans; In Situ Hybridization, Fluorescence; Lymphoma; Lymphoma, B-Cell; Prednisone; Retrospective Studies; Rituximab; Transplantation, Autologous; Vincristine | 2022 |
Evaluation of four chemotherapy regimens for treatment of advanced AIDS-associated Kaposi sarcoma in Kenya: a cost-effectiveness analysis.
Topics: Acquired Immunodeficiency Syndrome; Bleomycin; Cost-Benefit Analysis; Etoposide; HIV Infections; Humans; Kenya; Paclitaxel; Sarcoma, Kaposi; Vincristine | 2022 |
Life-threatening hemophagocytic syndrome triggered by disseminated toxoplasmosis in a young patient with previously unknown AIDS.
Topics: Acquired Immunodeficiency Syndrome; Etoposide; HIV Infections; Humans; Lymphohistiocytosis, Hemophagocytic; Male; Toxoplasmosis | 2022 |
HSV-2 triggers upregulation of MALAT1 in CD4+ T cells and promotes HIV latency reversal.
Topics: CD4-Positive T-Lymphocytes; Etoposide; Herpesvirus 2, Human; HIV Infections; Humans; RNA, Long Noncoding; Up-Regulation; Virus Latency | 2023 |
Predictive Value of Serum Biomarkers for Response of Limited-Stage AIDS-Associated Kaposi Sarcoma to Antiretroviral Therapy With or Without Concomitant Chemotherapy in Resource-Limited Settings.
Topics: Acquired Immunodeficiency Syndrome; Biomarkers; Chemoradiotherapy; Etoposide; HIV Infections; Humans; Inflammation; Interleukin-10; Ligands; Matrix Metalloproteinase 2; Receptors, Tumor Necrosis Factor; Resource-Limited Settings; Sarcoma, Kaposi; Vascular Endothelial Growth Factor A | 2023 |
Modified EPOCH for high-risk non-Hodgkin lymphoma in sub-Saharan Africa.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; CD4 Lymphocyte Count; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; HIV Infections; Humans; Lymphoma, Non-Hodgkin; Malawi; Male; Middle Aged; Neutropenia; Prednisone; Progression-Free Survival; RNA, Viral; Vincristine; Young Adult | 2020 |
Misdiagnosing multicentric Castleman's disease in an HIV-positive patient.
Topics: Castleman Disease; Diagnostic Errors; Etoposide; Fever; HIV Infections; Humans; Lymphadenopathy; Male; Middle Aged; Pancytopenia; Rituximab; Treatment Outcome | 2020 |
Outcomes of treatment with CHOP and EPOCH in patients with HIV associated NHL in a low resource setting.
Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hepatic Encephalopathy; HIV Infections; Humans; Infusions, Intravenous; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neutropenia; Prednisone; Retrospective Studies; Sepsis; Survival Rate; Thrombocytopenia; Time Factors; Treatment Outcome; Uganda; Vincristine | 2020 |
HIV-negative plasmablastic lymphoma attaining sustained remission with bortezomib-combined dose-adjusted EPOCH therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Cyclophosphamide; Doxorubicin; Etoposide; Female; HIV Infections; Humans; Middle Aged; Plasmablastic Lymphoma; Prednisone; Remission Induction; Vincristine | 2017 |
Triple therapy of vincristine, bleomycin and etoposide for children with Kaposi sarcoma: Results of a study in Malawian children.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Etoposide; Female; HIV Infections; HIV-1; Humans; Malawi; Male; Retrospective Studies; Sarcoma, Kaposi; Vincristine | 2018 |
DNA damage induced by topoisomerase inhibitors activates SAMHD1 and blocks HIV-1 infection of macrophages.
Topics: Cells, Cultured; DNA Damage; Etoposide; HIV Infections; HIV-1; Humans; Macrophages; Nucleotides; Phosphorylation; SAM Domain and HD Domain-Containing Protein 1; Topoisomerase II Inhibitors; Virus Replication | 2018 |
Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Carmustine; Cost-Benefit Analysis; Cyclophosphamide; Cytarabine; Etoposide; Female; HIV Infections; Humans; Ifosfamide; Male; Melphalan; Methotrexate; Middle Aged; Neoplasm Staging; Retrospective Studies; Rituximab; Survival Analysis | 2018 |
[Clinicopathological Characteristics and Prognosis Analysis of the Patients with Plasmablastic Lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; HIV Infections; Humans; Male; Middle Aged; Plasmablastic Lymphoma; Prednisone; Prognosis; Retrospective Studies; Vincristine | 2018 |
Case report: Treatment of metastatic germ cell tumor in a newly diagnosed HIV infected man: use of BEP chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; HIV Infections; Humans; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Testicular Neoplasms; Treatment Outcome | 2011 |
AIDS-lymphoma (ARL): one more step along the way.
Topics: Anti-HIV Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; HIV Infections; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Prednisone; Rituximab; Vincristine | 2013 |
Therapy of HIV-associated lymphoma-recommendations of the oncology working group of the German Study Group of Physicians in Private Practice Treating HIV-Infected Patients (DAGNÄ), in cooperation with the German AIDS Society (DAIG).
Topics: Anti-HIV Agents; Antibiotic Prophylaxis; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Castleman Disease; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Interactions; Etoposide; Hematopoietic Stem Cell Transplantation; HIV Infections; Humans; Lymphoma, AIDS-Related; Methotrexate; Neoplasm Staging; Prednisolone; Prednisone; Radiotherapy, Adjuvant; Risk Assessment; Rituximab; Vincristine | 2014 |
Etravirine: a good option for concomitant use with chemotherapy for Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Fever; HIV Infections; HIV-1; Hodgkin Disease; Humans; Male; Middle Aged; Nitriles; Prednisone; Procarbazine; Pyridazines; Pyrimidines; Reverse Transcriptase Inhibitors; Treatment Outcome; Vincristine; Viral Load | 2015 |
The pharmacokinetics of high-dose methotrexate in people living with HIV on antiretroviral therapy.
Topics: Adult; Aged; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Etoposide; Female; Half-Life; HIV Infections; Humans; Ifosfamide; Kidney Function Tests; Male; Methotrexate; Middle Aged; Retrospective Studies; Tenofovir; Vincristine; Young Adult | 2016 |
Autologous stem cell transplantation using MEAM regimen for relapsed AIDS-related lymphoma patients who received highly active anti-retroviral therapy: a report of three cases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; HIV Infections; Humans; Lymphoma, AIDS-Related; Male; Melphalan; Nitrosourea Compounds; Recurrence; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous | 2009 |
The successful treatment of haemophagocytic syndrome in patients with human immunodeficiency virus-associated multi-centric Castleman's disease.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Phytogenic; Antiretroviral Therapy, Highly Active; Castleman Disease; Combined Modality Therapy; Cytokines; Drug Therapy, Combination; Etoposide; Herpesvirus 8, Human; HIV Infections; Humans; Immunologic Factors; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Rituximab; Splenectomy; Young Adult | 2008 |
Dose-modified oral chemotherapy in the treatment of AIDS-related non-Hodgkin's lymphoma in East Africa.
Topics: Administration, Oral; Adolescent; Adult; Africa South of the Sahara; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; HIV Infections; HIV-1; Humans; Kenya; Lomustine; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Procarbazine; Treatment Outcome; Uganda; Virus Replication; Young Adult | 2009 |
Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt's lymphoma: a retrospective analysis.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; HIV Infections; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Retrospective Studies; Rituximab; Secondary Prevention; Vincristine | 2011 |
Clinical Features and Outcome in HIV-Associated Multicentric Castleman's Disease.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Castleman Disease; Comorbidity; Databases, Factual; Disease Progression; Disease-Free Survival; Drug Therapy, Combination; Etoposide; Female; Herpesviridae Infections; Herpesvirus 8, Human; HIV Infections; Humans; Incidence; Kaplan-Meier Estimate; Lymphoma, AIDS-Related; Male; Middle Aged; Proportional Hazards Models; Rituximab; Survival Analysis; Treatment Outcome; Young Adult | 2011 |
Multicentric Castleman's disease as a cause for unclear febrile episodes in a 55-year-old HIV-infected man.
Topics: Algorithms; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Phytogenic; Antiviral Agents; Castleman Disease; Drug Therapy, Combination; Etoposide; Ganciclovir; HIV Infections; Humans; Immunologic Factors; Male; Middle Aged; Rituximab; Seizures, Febrile; Treatment Outcome; Valganciclovir | 2012 |
Orbital plasmablastic lymphoma with remission following chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Filgrastim; Granulocyte Colony-Stimulating Factor; HIV Infections; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Multimodal Imaging; Orbital Neoplasms; Polyethylene Glycols; Positron-Emission Tomography; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recombinant Proteins; Remission Induction; Tomography, X-Ray Computed; Vincristine | 2011 |
Cell cycle arrest in G2/M promotes early steps of infection by human immunodeficiency virus.
Topics: Aphidicolin; Camptothecin; Cell Cycle; Cell Division; Cell Line; Dose-Response Relationship, Drug; Enzyme Inhibitors; Etoposide; G2 Phase; HIV; HIV Infections; Humans; Nucleic Acid Synthesis Inhibitors; Paclitaxel; Time Factors; Transduction, Genetic; Virus Replication | 2005 |
Current status of the treatment of HIV-associated lymphoma.
Topics: Anti-HIV Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Combined Modality Therapy; Cyclophosphamide; Disease Management; Doxorubicin; Drug Interactions; Etoposide; Hematopoietic Stem Cell Transplantation; HIV Infections; Hodgkin Disease; Humans; Lymphoma, AIDS-Related; Prednisone; Rituximab; Survival Analysis; Treatment Outcome; Vincristine | 2004 |
Multicentric Castleman's disease in a patient with HIV.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antiretroviral Therapy, Highly Active; Castleman Disease; Doxorubicin; Etoposide; Female; Herpesvirus 8, Human; HIV Infections; HIV-1; Humans; Liposomes | 2006 |
Treatment of HIV-associated Burkitt Lymphoma in the presence of severe hepatic dysfunction.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; HIV Infections; Humans; Liver Diseases; Male; Prednisone; Remission Induction; Vincristine | 2006 |
Cutaneous plasmablastic lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; HIV Infections; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Skin Neoplasms; Vincristine | 2008 |
Angina pectoris following cisplatin, etoposide, and bleomycin in a patient with advanced testicular cancer.
Topics: Adult; Angina Pectoris; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Coronary Vasospasm; Etoposide; HIV Infections; Humans; Male; Nitroglycerin; Retroperitoneal Neoplasms; Teratocarcinoma; Testicular Neoplasms | 1995 |
Infusional cyclophosphamide, doxorubicin, and etoposide in human immunodeficiency virus- and human T-cell leukemia virus type I-related non-Hodgkin's lymphoma: a highly active regimen.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; HIV; HIV Infections; HIV Seropositivity; HTLV-I Infections; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prognosis; Survival Analysis; Time Factors | 1993 |
Increased risk for opportunistic infections during chemotherapy in HIV-infected patients with Kaposi's sarcoma.
Topics: Adult; AIDS-Related Opportunistic Infections; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Candidiasis; Case-Control Studies; CD4 Lymphocyte Count; Cytomegalovirus Retinitis; Doxorubicin; Esophagitis; Etoposide; Follow-Up Studies; HIV Infections; Humans; Male; Pneumonia, Pneumocystis; Prognosis; Prospective Studies; Risk Factors; Sarcoma, Kaposi; Skin Neoplasms; Vinblastine; Vincristine | 1997 |
Interleukin-15 is a potent survival factor in the prevention of spontaneous but not CD95-induced apoptosis in CD4 and CD8 T lymphocytes of HIV-infected individuals. Correlation with its ability to increase BCL-2 expression.
Topics: Apoptosis; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Culture Techniques; Cell Division; Cell Survival; Cytoprotection; Etoposide; fas Receptor; HIV Infections; Humans; Interleukin-15; Nucleic Acid Synthesis Inhibitors; Proto-Oncogene Proteins c-bcl-2 | 1999 |
HIV-associated non-Hodgkin lymphoma: incidence, presentation, and prognosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Biopsy, Needle; Cyclophosphamide; Doxorubicin; Etoposide; Flow Cytometry; HIV Infections; Humans; Immunohistochemistry; Immunophenotyping; Incidence; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Thrombolytic Therapy; Venous Thrombosis; Vincristine | 2001 |
Treatment of HIV-associated multicentric Castleman's disease with oral etoposide.
Topics: Administration, Oral; Adult; Anatomy, Cross-Sectional; Antineoplastic Agents, Phytogenic; Castleman Disease; DNA, Viral; Etoposide; Herpesvirus 8, Human; HIV Infections; Humans; Male; Middle Aged; Radiography; Tomography Scanners, X-Ray Computed | 2001 |
Induction of a TRAIL-mediated suicide program by interferon alpha in primary effusion lymphoma.
Topics: Antimetabolites, Antineoplastic; Antiviral Agents; Apoptosis; Apoptosis Regulatory Proteins; Arabidopsis Proteins; bcl-X Protein; Biopolymers; Cysteine Endopeptidases; Drug Synergism; Enzyme Activation; Epstein-Barr Virus Infections; Etoposide; Fatty Acid Desaturases; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Herpesviridae Infections; Herpesvirus 4, Human; Herpesvirus 8, Human; HIV Infections; Humans; Immunocompromised Host; Immunologic Factors; Interferon-alpha; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Membrane Glycoproteins; Neoplasm Proteins; Proto-Oncogene Proteins c-bcl-2; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Thymidine; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Tumor Virus Infections; Zidovudine | 2001 |
Low-dose multidrug chemotherapy plus Pneumocystis carinii pneumonia prophylaxis for HIV-related Kaposi's sarcoma.
Topics: Administration, Inhalation; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Drug Therapy, Combination; Etoposide; Follow-Up Studies; HIV Infections; Humans; Male; Middle Aged; Opportunistic Infections; Pentamidine; Pneumonia, Pneumocystis; Sarcoma, Kaposi; Vinblastine; Vincristine | 1990 |